IDYA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- IDEAYA Biosciences reported a successful FDA Type C meeting supporting the Phase 3 registrational trial design of IDE849 in extensive-stage small cell lung cancerAug 31, 2026
- IDEAYA Biosciences entered a clinical collaboration with Genentech to evaluate therapies in MTAP-deleted, KRAS G12D-mutant pancreatic cancerAug 19, 2026
- IDEAYA begins Part 2 expansion of Phase 1/2 study for IDE892 in MTAP-deleted pancreatic and lung cancersJul 27, 2026
- IDEAYA initiated a Phase 1/2 combination study of IDE892 in MTAP-deleted pancreatic and lung cancersJun 15, 2026
- IDEAYA Biosciences announced a clinical collaboration with Roche in MTAP-deleted RAS-mutant pancreatic cancerJun 3, 2026